Understand the findings.
Know your options and when to seek help.
Based on published clinical guidance · Last updated 29 October 2026
Diabetic retinopathy is damage to the small blood vessels in the retina caused by diabetes. The retina is the light-sensitive lining at the back of the eye. Changes can develop before your sight feels different, so detecting disease early is different from waiting until you need stronger glasses or notice discomfort. [1][11]
Diabetic macular oedema means swelling in the macula, the central area responsible for detailed sight. It can occur alongside different stages of retinopathy and affect reading or recognising faces. An assessment establishes whether blur comes from swelling, bleeding, cataract or another condition; not every visual problem in someone with diabetes has the same cause. [3][5]
This guide covers diabetic retinopathy and diabetic macular oedema rather than every retinal disorder. A retinal vein blockage, macular hole or retinal tear needs its own diagnosis and plan. Tell the clinician about previous screening results, injections, laser, eye operations and any sudden change, because these details can alter the urgency and treatment discussion. [3][12]
Early diabetic retinopathy may have no symptoms. Later changes can include blurred or fluctuating sight, dark floating spots or streaks, and reduced vision. A clear view of familiar objects does not establish that the retinal blood vessels are healthy. Attend screening invitations even when you read comfortably and your usual glasses still seem effective. [11]
New floaters can arise when abnormal vessels bleed into the vitreous, the clear gel inside the eye. They can also have other causes, including a retinal tear. A sudden shower of spots, a curtain or sudden loss of vision needs urgent assessment rather than an assumption that this is an ordinary fluctuation in diabetes. [11][12]
Contact an eye-care professional about a new change between screening appointments. HSE advice is explicit that you should not wait for your next screening invitation. Describe when it started, which eye is affected and whether it is getting worse. A screening programme finds risk in a population; it is not an emergency symptom-assessment service. [2]
Ireland’s Diabetic RetinaScreen programme is for people with diabetes aged 12 years and older. It is free and requires registration and consent. Screening uses retinal photographs to look for diabetic changes; the invitation is not dependent on noticing poor sight. Ask your GP or diabetes team about registration if you are not receiving invitations. [1]
Most people are screened once a year. HSE states that, after no retinopathy in the last two screenings, the next invitation can be in two years. Some people need closer digital surveillance or referral for treatment. This screening interval is not the timetable for someone already receiving injections, laser or specialist monitoring. [1][2]
Continue regular eye examinations as well as diabetic screening. HSE explains that screening does not detect every eye condition and is not completely reliable. A normal result does not explain away later symptoms, check a glasses prescription or replace assessment of glaucoma and cataract. Follow the advice in your result letter and report changes promptly. [1][2]
In general clinical guidance, assessment considers your symptoms, visual acuity, medical and eye history, and a retinal examination, often through dilated pupils. The doctor looks for leaking vessels, haemorrhages, abnormal new vessels and scar tissue. Screening photographs can support the referral, but the specialist examination identifies what needs monitoring or treatment and whether other eye disease affects the outlook. The tests described here are general diagnostic methods, not a promised first-visit package. [3]
OCT uses light to produce cross-sectional retinal images and identify macular swelling. NICE specifically recommends OCT when assessing for diabetic macular oedema. It helps show whether the central retina is involved and monitor treatment response. A scan finding is interpreted alongside vision and examination; a thicker retina alone does not determine every treatment decision. [4][3]
Additional retinal photographs or dye imaging may be useful when the blood supply or abnormal vessels need clarification. Tell the team about previous reactions and bring earlier results if available. Ask what each test is intended to answer and whether drops will affect your journey home. Do not drive while dilation or blurred vision makes driving unsafe. [3][14]
Long-term glucose management reduces the risk of diabetic retinal complications. The DCCT established the benefit of intensive diabetes management in its studied population. This supports working with your diabetes team on an individual plan; it does not justify rapidly changing insulin or other medicines yourself to chase a retinal test result. [9]
Blood pressure matters as well as glucose. UKPDS demonstrated benefits from blood-pressure control in people with diabetes and hypertension. NICE advises managing hypertension, but not prescribing blood-pressure medicines solely for retinopathy prevention in someone without hypertension. Share retinal results with your diabetes team so eye care and general medical care support the same plan. [10][4]
Pre-existing diabetes in pregnancy needs a specific retinal assessment pathway because retinopathy can worsen. Tell your maternity and diabetes teams if you are pregnant or planning pregnancy, and mention any proposed eye injection. NICE distinguishes pregnancy-related retinal assessment from ordinary follow-up. Your medicine and monitoring decisions should be coordinated rather than based on the general screening interval. [13][2]
Not every retinal change needs an injection or laser immediately. The stage of retinopathy, whether the macula is involved, your visual function and the risk of progression all matter. Monitoring is an active plan with a review date and return precautions; it should not mean leaving new symptoms unassessed or losing contact with the eye-care team. [3][4]
For selected people with centre-involving swelling but good starting vision, the Protocol V trial found similar vision-loss results with initial injections, laser or careful observation. Observation included treatment if vision worsened. That is a monitored treatment strategy, not evidence that all macular swelling can safely be ignored or that established poor vision should be left untreated. [8]
Proliferative retinopathy means abnormal new retinal vessels, which can bleed and cause scarring. Laser and anti-VEGF treatment have different benefits and practical demands. Protocol S supports considering the ability to attend visits when choosing treatment. Discuss transport, caring responsibilities and previous missed appointments before agreeing to a plan that depends on repeated injections. [7]
Our clinic offers intravitreal anti-VEGF injections when clinically appropriate. Anti-VEGF medicines reduce a signal involved in abnormal vessel growth and leakage. They are injected into the eye so the medicine reaches the retina. Treatment can reduce macular swelling and protect or improve vision, but the achievable benefit depends on the retinal condition and existing damage. A treatment course and continuing assessment are often needed. [15]
Protocol T compared anti-VEGF medicines using a structured treatment schedule. Vision improved across the studied groups, while the relative benefit depended partly on how well people could see before treatment. The practical choice is therefore not simply which name is newest: starting vision, previous response, safety, licensing and the treatment pathway all enter the discussion. [6]
Cochrane found that several anti-VEGF medicines can improve vision in diabetic macular oedema, with limited evidence for clear visual differences between some medicines at longer follow-up. This does not mean that every drug is interchangeable for every eye. Discuss the proposed medicine and how success will be assessed rather than expecting a guaranteed gain from a trial average. [5][6]
Panretinal laser treats areas of peripheral retina to reduce the drive for abnormal new vessels. Its purpose is to reduce the risk of severe complications, rather than immediately sharpen central sight. Treatment can affect peripheral or night vision, so the potential benefits and visual trade-offs should be explained before consent, including any implications for work and driving. [3][7]
Macular laser has a different role and is considered for selected patterns of diabetic macular oedema. Laser aimed at proliferative disease should not be confused with treatment directed at swelling. Ask which problem is being treated and how the proposed approach fits with injections or observation. A label such as diabetic laser is not a complete treatment explanation. [4][3]
Vitrectomy may be needed for bleeding that does not clear or scar tissue pulling on the retina. Surgery addresses the structural problem; it does not cure diabetes or remove the need for follow-up. The surgeon explains the likely benefit, risks, medicines and any gas-related restrictions. Do not assume that another person’s retinal operation will have the same aftercare. [12][3]
Specialist review can be more frequent than routine screening. NICE gives examples of every 6–12 months for untreated moderate non-proliferative disease and every 3–6 months for severe or very severe disease. These are UK guideline ranges for defined situations, not an Irish screening rule or this clinic’s appointment schedule. Treatment and new symptoms can require earlier assessment. [4]
After injections or laser, the team checks vision and retinal findings to decide whether treatment needs repeating, changing or pausing. A dry-looking scan or improved sight is useful information but does not automatically mean the underlying risk has disappeared. Protocol S highlights why continued attendance is important when proliferative disease is managed with repeated treatment. [7]
Keep your screening programme and treating team informed about changes in care. Hospital follow-up and screening invitations are different services; do not cancel a treatment appointment because a screening photograph looked reassuring. Ask who is responsible for your next assessment, what the expected contact route is and what to do if an invitation or appointment does not arrive. [2][3]
An injection appointment includes safety checks and cleaning the eye, with anaesthetic drops to numb the surface. You may feel pressure or a brief scratch. Tell the team about an infected or sticky eye, allergies, pregnancy and relevant recent illnesses. These details help decide whether treatment should proceed and what precautions or discussion are appropriate. [14][15]
Mild surface grittiness or a small red patch can occur after an injection, but worsening pain or reduced vision needs urgent contact. Follow the written instructions from the treating service rather than copying another hospital’s drop schedule or restrictions. If dilation or treatment affects your sight, arrange transport and resume driving only when safe and appropriate. [14]
Bring your current glasses, medicines and details of previous laser or injections to the visit. Tell the team about diabetes care, pregnancy plans and difficulties attending. The consultation should connect the retinal findings with the tasks you need your vision for, including reading, work and caring responsibilities, rather than discussing a scan in isolation. [3][13]
Sudden loss of vision, a curtain-like shadow or a new shower of floaters requires urgent eye assessment. Bleeding or retinal detachment are possible explanations, and neither can be excluded by having attended screening recently. Contact an urgent eye service; if you cannot reach an appropriate team promptly, attend an emergency department rather than waiting for routine screening. [11][2]
Severe or increasing pain, worsening redness, discharge or a reduction in vision after an injection or operation needs urgent review. Infection inside the eye is a possible serious complication. Do not assume that deterioration is expected healing or try to manage it solely with extra lubricant. Explain which treatment you had and when the symptoms began. [14]
For gradual visual changes without an emergency symptom, contact your eye-care professional rather than waiting for the next invitation. Continue diabetes care and attend the reviews you are given. There is no single recovery timetable or personal vision guarantee: the priority is recognising a change early enough for the cause to be assessed and an appropriate plan made. [2][12]
At Limerick Eye Clinic
Retinal assessment and intravitreal anti-VEGF injections when clinically appropriate, with treatment and monitoring tailored to your response.
Retinal laser and retinal surgery are not performed at our clinic. If they are suitable for you, we arrange onward care.
Your glasses, a list of your medicines and any previous letters or reports. A referral letter can be uploaded with your appointment request.
+353 61 52 6664
reception@limerickeyeclinic.ie
Yes; the early stages often have no symptoms, so apparently clear vision does not rule out retinal damage. NEI explains that changes can develop before you notice reading or distance problems. Attend screening invitations and ordinary eye examinations, and report a new visual change between visits rather than waiting until the eye becomes painful. [11]
Yes; both type 1 and type 2 diabetes can cause diabetic retinopathy. HSE includes both in Diabetic RetinaScreen. The risk and timing of changes vary with your history and medical factors, so your eye-care plan should reflect your findings rather than the diabetes label alone. Bring details of previous screening and any retinal treatment. [1][3]
It is swelling in the macula, the central retina used for detailed vision. Cochrane explains that leakage associated with diabetes can thicken this area and reduce sight. It is related to retinopathy but is not the same as every retinal change. OCT and examination help establish whether swelling explains your symptoms and what treatment is appropriate. [5][4]
Yes; diabetic retinopathy can cause serious permanent sight loss if it is not detected and managed. HSE explains that early detection and treatment can reduce damage. Blindness is not inevitable, and an individual outlook depends on the retinal findings. Keep appointments even when vision feels normal and seek assessment promptly for a new change. [1][11]
Irish care context, specialist guidance and clinical studies. Published outcomes describe the studied populations, not this clinic’s outcomes.
Based on published clinical guidance · Last updated 29 October 2026
A conversation is a good place to start.
+353 61 52 6664 · reception@limerickeyeclinic.ie
At your pace. With your questions. For your eyes.
